---
title: "300453.SZ (300453.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300453.SZ/news.md"
symbol: "300453.SZ"
name: "300453.SZ"
parent: "https://longbridge.com/en/quote/300453.SZ.md"
datetime: "2026-05-20T02:38:38.490Z"
locales:
  - [en](https://longbridge.com/en/quote/300453.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300453.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300453.SZ/news.md)
---

# 300453.SZ (300453.SZ) — Related News

### [Sanxin Medtec: Plans to conduct foreign exchange hedging business not exceeding 200 million yuan](https://longbridge.com/en/news/286919119.md)
*2026-05-19T13:10:24.000Z*
> Sanxin Medtec announced plans to conduct foreign exchange hedging business not exceeding 200 million yuan to mitigate ex

### [Sanxin Medtec: Plans to use its own funds of 17.8724 million yuan to acquire a portion of the equity held by Chen Guiwen and Liu Shaolin in Chengdu Weili Sheng](https://longbridge.com/en/news/281497211.md)
*2026-04-02T09:21:14.000Z*
> Sanxin Medtec announced that its wholly-owned subsidiary Sichuan Weili Sheng plans to use CNY 17.8724 million of its own

### [Sanxin Medtec has obtained EU MDR certification for multiple products](https://longbridge.com/en/news/279399133.md)
*2026-03-17T09:03:51.000Z*
> Sanxin Medtec recently obtained the EU Medical Device Regulation (MDR) certification issued by the German Rhine TÜV Grou

### [](https://longbridge.com/en/news/278989016.md)
*2026-03-13T05:43:16.000Z*
> A-share medical consumables stocks continue to rise, ZHYL and INTCO are approaching a 20% limit-up, Allmed Medical and B

### [Sanxin Medtec's net profit attributable to the parent company for the year 2025 is 262 million yuan, an increase of 15.43%](https://longbridge.com/en/news/277174871.md)
*2026-02-27T09:41:15.000Z*
> Sanxin Medtec released its performance report for the year 2025, with total operating revenue of 1.64 billion yuan, a ye

### [Sanxin Medtec: Shareholder Peng Jiulian reduced holdings by 2.2644 million shares](https://longbridge.com/en/news/269088618.md)
*2025-12-09T12:56:42.000Z*
> Sanxin Medtec announced that shareholder Peng Jiulian reduced her holdings in the company by 2.2644 million shares throu

### [Sanxin Medtec released its performance for the first three quarters, with a net profit attributable to the parent company of 185 million yuan, an increase of 10.16%](https://longbridge.com/en/news/263341710.md)
*2025-10-29T16:19:06.000Z*
> According to the Zhitong Finance APP, Sanxin Medtec released its third-quarter report for 2025. The company's operating 

### [Western Securities: The time for domestic substitution of blood dialysis is right; optimistic about major products, diversification, and overseas expansion](https://longbridge.com/en/news/259457053.md)
*2025-09-30T06:04:05.000Z*
> Western Securities released a research report indicating that the market for blood dialysis medical devices in China is